
News|Articles|October 5, 2026
How Distribution Is Evolving for Today's Targeted Therapies
Author(s)Christopher Van Norman, Stephen Appezzato
McKesson's Chris Van Norman previews his LogiPharma USA keynote on demand signal sharing, AI, and precision distribution for targeted therapies.
Advertisement
Advertisement
As therapies become more targeted and time-sensitive, distribution is demanding more specialized handling, tighter temperature control, and closer coordination between manufacturers and distributors. Christopher Van Norman, senior vice president of supply chain operations at McKesson, addresses those demands at LogiPharma USA 2026, as a speaker in the keynote fireside chat "Racing to Meet the Moment: Supply Chains Built for Today's Therapies."
Related to this article

LogiPharma's Charleen Ring and McKesson's Chris Van Norman preview the 2026 agenda, sessions to prioritize and a day two fireside chat.

Informa's invitation-only Leadership Summit returns to CPHI Milan Oct. 6 as executives weigh sourcing, medicine security and reshoring pressure.

Go behind the scenes of LogiPharma USA 2026 with program director Charleen Ring and McKesson's Chris Van Norman in this Pharma Pulse special.

Cardinal Health and McKesson moved to extend CVS Health distribution deals through June 2032, retaining their largest customer pending final contracts.

Inside the October 2026 issue: why splitting MMR takes years, why payers cite a price that does not bind them, and what pricing rules broke.

Patient support data that is trusted, connected and delivered into field workflows can move access teams from reporting to faster patient intervention.

In this week's Pharma Pulse, the EU Council adopts the "pharma package," Commerce details 0% tariffs for certain drugs and Sharp expands autoinjector assembly capacity.
Advertisement
Advertisement

